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Abstrak 
Sel punca merupakan sel yang dapat membelah dan berdiferensiasi menjadi sel jenis lainnya. Sel 
punca asal jaringan lemak potensial dikembangkan sebagai salah satu alternatif sel punca yang 
bersumber dari limbah sedot lemak manusia. Sel punca asal jaringan lemak akan mengekspresikan 
protein spesifik penanda permukaan CD73, CD90, CD105 dalam persentase yang tinggi dan 
CD34/CD45/CD11b/CD19/HLA-DR dalam persentase yang rendah. Studi ini bertujuan untuk 
memanfaatkan limbah sedot lemak manusia dengan melakukan isolasi sel punca asal jaringan lemak 
dan menguji protein penanda permukaan spesifik sel punca. Beberapa tahapan dalam studi ini 
adalah isolasi stromal vascular fraction (SVF) dan kultur sel punca asal jaringan lemak manusia, 
population doubling time (PDT) serta analisis protein penanda permukaan CD7Ee3, CD90, CD105, 
dan CD34/CD45/CD11b/CD19/HLA-DR pada pasase ke-1 dari 3 donor. Hasil dari studi ini 
menunjukkan bahwa sel dari jaringan lemak berhasil dikultur dengan durasi pembelahan sel adalah 
3,3 hari. Sel mengekspresikan CD73 (99,79%), CD90 (94,17%), CD105 (48,75%), dan 
CD34/CD45/CD11b/CD19/HLA-DR (kurang dari 2%). Ekspresi CD105 yang rendah dari ketiga 
donor diduga berkaitan dengan tingkatan pasase sel yang digunakan. Berdasarkan hasil tersebut 
dapat disimpulkan bahwa sel punca asal jaringan lemak pasase ke-1 telah mengekspresikan ketiga 
marker protein penanda permukaan sel punca, yaitu CD73, CD90 dan CD105.  
Kata kunci: CD73; CD90; CD105; Jaringan lemak; Protein permukaan; Sel punca 
Abstract  
Stem cells are cells that can divide into other different types of similar cells. Stem cells from fat tissue 
potential have been developed as an alternative stem cell from human liposuction. Stem cells from fat tissue 
will express high protein-specific markers on CD73, CD90, CD105 and CD34/CD45/CD11b/CD19/HLA-DR 
in a low percentage. This study aims to utilize human liposuction waste by isolating stem cells from fat tissue 
and testing protein-specific stem cell surface markers. Some stages in this study are isolation of stromal 
vascular fraction (SVF) and stem cell culture from human fat tissue, population doubling time (PDT) and 
protein analysis of surface markers CD73, CD90, CD105, and CD34/CD45/CD11b/CD19/HLA-DR on the 
1st passage of 3 donors. The results of this study showed that cells from fat tissue were successfully cultured 
with cell division duration of 3.3 days. Cells expressed CD73 (99.79%), CD90 (94.17%), CD105 (48.75%), 
and CD34/CD45/CD11b/CD19/HLA-DR (less than 2%). The low expression of CD105 from all three donors 
is thought to be related to the level of cell passage used. Based on these results, it can be concluded that the 
stem cells from first passage fat tissue have expressed the three protein markers of stem cell surface markers, 
namely CD73, CD90 and CD105. 
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INTRODUCTION 
Stem cells are cells that can renew 
themselves and differentiate into other types of 
cells (Nicoletti, De Francesco, D'Andrea, & 
Ferraro, 2015). Stem cells were first 
discovered in the 19th century grouped into two 
based on their sources, which is sourced from 
embryonic (embryonic stem cells) and adult 
tissue (adult stem cells) (Zuk, 2010). Stem 
cells from embryonic are pluripotent, which 
can differentiate into many types of cells, 
whereas stem cells from adult tissue are 
multipotent/unipotent, which can differentiate 
into three or one cell types only. Embryonic 
stem cells have weaknesses related to ethics, so 
stem cells from adult tissue are more 
commonly used as cell sources in research 
(Robertson, 2010; Kern, Eichler, Stoeve, 
Klüter, & Bieback, 2006). The ability and 
manipulation techniques of stem cells from 
adult tissues are still being developed, 
researched and studied. Some sources of stem 
cells from adult tissues that have been 
developed recently are stem cells from 
muscles, nerves, umbilical cord, blood, bone 
marrow and fat tissue (Zuk, 2010; Mennan et 
al., 2013). 
Stem cells from fat tissue (adipose-
derived stem cells or ADSCs) are a source of 
stem cells that are widely used because they 
are thought to originate from liposuction 
surgery waste (Zuk, 2010). The number of 
ADSCs is also 5 to 50 times more than bone 
marrow stem cells (bone marrow mesenchymal 
stem cells or BMSCs). The characteristics of 
ADSCs are almost the same as bone marrow 
stem cells, but the advantages of ADSCs 
compared to bone marrow stem cells include 
that stem cells can be obtained more with more 
accessible procedures and lower risk. The 
comparison of the number of BMSCs with 
ADSCs is 100–1,000 cells with ~5,000 cells. 
Both sources of stem cells can be grown 
(cultured) on Dulbecco's Modified Eagle's 
(DMEM) medium (Gibco) which generally 
contains 10% fetal bovine serum (FBS) (Zhu et 
al., 2008; Pawitan, 2009). 
BMSCs express the certain surface 
marker proteins (surface markers) that are 
characteristic of mesenchymal stem cells 
(Mennan et al., 2013; Zhang, Meng, Zhang, 
Chen, & Wang, 2017). Stem cell surface 
markers from fat tissue do not yet have a 
certain standard consensus. The International 
Society for Cellular Therapy (ISCT) sets the 
standard for BMSCs surface markers, namely 
hematopoietic markers. CD34/CD45/CD11b/ 
CD19/HLA-DR must be negative or less than 
2%, while maximal markers CD73, CD90, 
CD105 must be more than 95% (Dominici et 
al., 2006). Surface marker proteins of CD73, 
CD90, CD105 have been confirmed that these 
proteins are also expressed in stem cells from 
fatty tissue origin by Zhang et al. (2017). 
Therefore, in this study, an analysis of human 
ADSCs surface marker protein expression 
analyze was conducted to study and prove the 
level of surface protein expression of CD73, 
CD90, and CD105. Stem cells are obtained 
from a stromal vascular fraction (SVF) which 
is enzymatically isolated in fat tissue and 
cultured until the 1st passage. The duration 
needed for cells to divide is also analyzed 
using population doubling time (PDT) 
techniques. 
MATERIALS AND METHODS  
Isolation of Stromal Vascular Fraction 
(SVF) 
Stromal vascular fraction (SVF) cells 
were isolated from 3 donors of lipoaspirate fat 
tissue under a woman's skin. Isolation of 
human ADSCs refers to the protocol of 
Remelia, Rosadi, Sobariah, Rosliana, and 
Karina (2016), which performs the process of 
fat tissue digestion in the solution of the 
recombinant H-Remedy enzyme. As many as 
10% of the recombinant enzyme was added to 
the fat tissue samples by incubation at a 
temperature of 37 C, 300 rpm, for 1 hour. The 
enzyme was then activated by adding 
Dulbecco's Modified Eagle's (DMEM) low 
glucose (LG) media (1 g/L) containing L-
glutamine (4 mM) (Gibco, USA) and 
centrifuged at 600 xg for 5 minutes. The 
supernatant formed in the upper layer then 
discarded, and re-centrifuged at 600 xg for 10 
minutes. SVF cell pellets containing ADSCs 
cultured at 37 C, 5% CO2.  
ADSC Culture 
Stem cells were cultured in the DMEM 
standard medium (Gibco, USA) which had 
been given antibiotic-antimycotic concen-
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tration 100x (Gibco, USA). Culture medium 
was changed every three days to maintain cell 
growth. Cells that have experienced 80% 
confluence were then harvested. Cells that will 
be harvested were washed first using Hank's 
Balanced Salt Solution (HBSS) (Gibco, USA). 
Then added Triple Select (Gibco, USA) and 
incubated for 5−10 minutes in the incubator 
CO2 37 C. Stem cells that have been separated 
(detach), then added DMEM growth medium 
containing 10% fetal bovine serum (FBS) 
(Gibco, USA). The cell was then centrifuged at 
600 xg for 5 minutes. The number of cells was 
calculated using a haemocytometer with 0.4% 
trypan blue solution (Sigma-Aldrich). The 
number of cells was then cultured for 
multiplication to get a passage 1 (P1). They 
were then analyzed by population doubling 
time (PDT) and specific-protein stem cell 
surface marker.   
Population Doubling Time (PDT) 
PDT is calculated based on the number of 
Stem cells from passage 0 human fat tissue 
implanted in the flask with the required 
duration of time. To be calculated until the cell 
undergoes confluence. The average number of 
cells cultured for PDT is 5000/cm² cells. This 
test is used to find out how long a cell divides 
from one into two cells. PDT is analyzed using 
the following formula: 
 ,  
where Δt= time from planting to harvest cells, 
NH= total cells were harvested, NI= total cells 
that were grown. The average PDT from 
various stem cell donors was then tabulated 
and analyzed. 
Analysis of Protein Expressions CD73, 
CD90, CD105 and CD34/CD45/CD11b/ 
CD19/HLA-DR 
The first passage cell was harvested and 
washed with HBBS then centrifuged 1,200 
rpm for 10 minutes. Then  the cell was 
resuspended in MACSQuant running buffer 
(130−092−747) 1 mL. A total of 15 μL cell 
suspensions were used to calculate the number 
of cells and the remainder was used for flow 
cytometry checks. The kit for checking ADSCs 
mesenchymal characters consists of several 
antibody cocktails listed on the BD Stemflow 
™ hMSC Analysis Kit. Each tube was labelled, 
and 2 µL reagents were added, as in the 
provisions in Table 1. 
Table 1. Description label and contents of flow cytometry inspection tubes for ADSCs 
characterization 
Tube No. Content Purpose 
1 Cell + FITC Mouse Anti-human CD90 Compensation 
2 Cell + PE Mouse Anti-human CD44 Compensation 
3 Cell + PerCP-CyTM5.5 Anti-human Mouse CD105 Compensation 
4 Cell + APC Mouse anti-human CD73 Compensation 
5 Cell Instrument setting 
6 Cell + PE hMSC Negative Isotype Control Cocktail + PE hMSC 
Negative Isotype Control Cocktail 
Gatting 
7 Cell + hMSC Positive Cocktail + PE hMSC Negative Cocktail Sample analysis 
 
Cells that have been added by reactor are 
vortexed, then incubated for 30 minutes in a 
dark room (covered with aluminium foil and 
put in a shelf). Then the cell suspension is 
centrifuged for 10 minutes, 1,200 rpm. Then 
the cell pellets are washed with 500 µL BD 
FacsFlow and centrifuged (1,200 rpm, 5 
minutes). Cell washing was conducted twice. 
Then the cell is resuspended in a 300 µL 
MACSQuant running buffer and read with a 
flow cytometer. The sample readings start 
sequentially with the following conditions: (1) 
Tube 5 which contains only cells, the result of 
reading is used to determine the cell population 
that will be analyzed (gatting); (2) Tube 6, 
which contains cells and mixture of isotype 
control for positive and negative cocktail, the 
result of reading is also used for determining 
cells population that will be further analyzed; 
this step was conducted to get rid of the non 
specific binding of Fc receptor with antibody 
or other cellular protein interaction that might 
occur, so that the specific the specific antibody 
primer reagen and antigen on cell can be 
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confirmed; (3) Tube 1 containing cells and 
FITC Mouse anti human CD90; this phase was 
conducted to compensate the overlap 
fluorochrome PE and FITC; (4) Tube 2 which 
contains cells and PE anti human mouse 
CD44; this phase was conducted to 
compensate the overlap fluorochrome PE and 
FITC; (5) Tube 3 containing cels and PerCP-
CyTM5.5 Mouse anti human CD105; this step 
was conducted to compensate for overlapping 
fluochromespectra PerCP-CyTM5.5 and APC; 
(6) Tube 4 containing cells and pc Mouse Anti 
Human Cd73; this step was conducted to 
compensate for overlapping fluorodromes-
pectra PerCP-CyTM5.5 and APC; (7) Tube 6 
containing cells and mixture of isotype control 
for positive and negative cocktail for 
reconfirmation of gatting; (8) Tube 7 which 
contains cells and mixture of positive and 
negative coctails for reading real sample. 
The surface  markers analyzed were 
CD73, CD90 and CD105 markers (positive 
>95%) and CD34/CD45/CD11b/CD19/HLA-
DR (positive <2%) markers according to 
criteria established by the Mesenchymal and 
Tissue Stem Cell Committee of the 
International Society for Cellular Therapy 
(ISCT) (Dominici et al., 2006 ). 
RESULTS 
Total SVF cells obtained and cultured 
from a variety of donors varies with an average 
of 1.18x108 cells SVF. The average SVF cell 
viability of the three donors was 98.90% 
(Table 2). Stem cells from SVF cultures have 
been observed attached to the bottom of the 
flask. Morphological forms of stem cells are 
like fibroblast cells. The time needed for stem 
cells in passage 0 to reach the confluence of 
each donor has a different time span. Cell 
confluence of more than 80% is presented in 
Figure 1.  
The average confluence of passage 0 (P0) 
cells was 13.5 days with an average number of 
stem cells obtained 3.2x105 cells. P0 stem cells 
are reproduced again to passage 1 (P1) with an 
average cell harvest value of 9.6x105 cells and 
with the duration of time needed for confluent 
is 7.5 days. PDSC values of ADSCs from all 
three donors indicate that cells need time to 
divide into two cells for 3.3 days. Based on 
these results shows that ADSCs from the three 
donors have been successfully cultured and 
propagated for further analysis of specific 
protein surface stem cell markers.  
 
Figure 1. Morphology of stem cells from human fat tissue attached to the bottom of the cup and 
reaching confluence on day 15, Passage 0, Magnification 10x, Optilab, Nikon 






Passage stem cells (P) 
PDT 






Donor-1 female 63,000,000 98.4 370,000 12 1,013,000 10 3,4 
Donor-2 female 150,000,000 98.68 270,000 15 920,000 5 2.8 
Donor-3 female 143,550,000 99.62  750,000 17  970,000   11 3,7 
Average 118,850,000 98.9 320,000 13.5 966,500 7.5 3,3 
 
Human passage 1 (P1) ADSCs from all 
three donors expressed the positive protein 
surface markers CD73, CD90 and CD105 
presented in Figure 2. The X-axis on the 
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histogram with two blue and red peaks 
indicates the intensity of fluorescence detected 
while the Y-axis indicates the number of cells. 
The peak of the histogram in red is the isotype 
of the sample while the peak of the histogram 
in blue is the luminescence of the sample that 
has been labelled with specific antibodies 
namely CD73, CD90, CD105 and 
CD34/CD45/CD11b/CD19/HLA-DR. The 
percentage of surface proteins expressed 
positive stem cells from a population 
quantified by means of overlap (overlay) 
between the peak sample histogram and 
isotype. Positive stem cells expressing surface 
proteins located on the right, the histogram is 
blue while the isotype is shown on the 
histogram in red (Figure 2). 
 
   
   
   
   
Figure 2. The percentage value of passport 1 human ADSCs surface protein from the three donors 
namely donor 1 (a-d), donor 2 (e-h), and donor 3 (i-l) with the peak of the histogram in 
blue showing the percentage value of the sample while the peak of the histogram in red 
shows the isotype. The surface protein expressions of CD73, CD90, and CD105 are 
shown in figures a, e, i; b, f, j and c, g, k in all three donors. Expression of negative 
surface marker proteins for stem cells (CD34/CD45/CD11b/CD19/HLA-DR) is shown 
in figures d, h, l in all three donors. The percentage value of P1 / P9 for each figure (al) 
shows the percentage value of protein expressed by the sample 
 
Based on the results obtained, the CD73 
surface marker protein is consistently 
expressed more than any other protein, which 
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donors 1, 2, and 3 for the CD73 surface marker 
protein, respectively, were 98.83%; 99.62% 
and 99.92%. The protein expression of the 
third donor CD90 surface marker is expressed 
more than 90% with the highest percentage of 
CD90 expression found in donor 2, which is 
expressed as much as 99.39%. CD90 
expression by cells from donors 1 and 3 was 
92.91% and 90.21%. Results with a low 
percentage of expression consistently occur on 
CD105 markers in all three donors. The 
percentage values of the three donors are 
54.51%; 54.05% and 37.69%. The negative 
protein expression of the stem cell surface 
marker i.e. CD34/CD45/CD11b/CD19/HLA-
DR is less than 2% (Figure 3). 
 
Figure 3. CD73, CD90, CD105 and CD34 / CD45 / CD11b / CD19 / HLA-DR (negative) surface 
marker protein percentage values of passage 1 human ADSCs 
 
DISCUSSION 
Stromal vascular fraction (SVF) consists 
of diverse (heterogeneous) cell populations 
such as ADSCs, hematopoietic stem cells, 
precursor cells, endothelial cells, regulatory T 
cells, macrophages, and preadipocytes 
(Nguyen et al., 2016; Bora & Majumdar, 
2017). The number of ADSCs is ~2–10%, then 
hematopoietic stem cells around 0.004%, 
macrophages around ~10%, T cells range from 
5–70%, and endothelial progenitor cells range 
from 7–30% (Dykstra et al., 2017). The 
selection of these cells can be made by 
administering a specific medium for specific 
cell growth, such as DMEM. Various cells 
contained in the SVF can be classified into 2, 
namely cells attached to the base of the flask 
(adherent) and cells that are not attached or 
floating (non-adherent). ADSCs have 
characteristics attached to flask so that it is 
quite easy to separate them from other non-
adherent cell types through periodic media 
replacement. Stem cells from all three donors 
have different proliferation rates indicated by 
the length of time the cell divides in PDT data.  
The mean value of PDT is ideal for stem 
cell growth, according to Mark et al. (2013) is 
2.6 to 4 days. These data indicate that the 
condition of stem cells from fat tissue in this 
study can divide well. The protein contained in 
the media influences the rate of stem cell 
division. Protein fibroblast growth factor 
(FGF) is a significant factor in the initiation of 
stem cell division from fat tissue with a 
medium containing FBS (Wang, Kim, Vunjak-
Novakovic, & Kaplan, 2006; Gentile, 2012). 
Some other growth factor proteins are platelet-
derived growth factor (PDGF), vascular 
endothelial growth factor (VEGF), 
transforming growth factor- β (TGF-β), and 
macrophage inhibitory factor (MIF) (Kang, 
Jeon, & Song, 2005; Palumbo, Tsai, & Li, 
2014; Atashi, Jaconi, Pittet-Cuenod, & 
Modarressi, 2014). PDGF, FGF and MIF 
proteins will bind to their respective receptors 
to stimulate the AKT signalling. The AKT 
signalling pathway activates protein synthesis 
for cell growth and inhibits apoptosis (Atashi 
et al., 2014). Activation of AKT pathway can 
increase ADSC proliferation through the 
expression of cell cycle-related proteins such 
as cyclin D1 protein to be higher (Atashi, 
Serre-Beinier, Nayernia, Pittet-Cuénod, & 
Modarressi, 2015). Cells that experience 
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growth (proliferation), will also express 
specific surface proteins.  
Protein markers of specific surface cells 
from fat tissue in uncultured SVF such as 
CD73, CD90 and CD105 have not been widely 
expressed. The CD73 marker, also known as 
ecto-5-nucleotidase, is a protein found in many 
types of tissue and plays a role in cell 
interactions with cells and cells with a matrix 
(Zhang, 2010). CD90 glycoproteins found on 
cell surfaces are found in stem cells, fibroblast 
cells, and activated endothelial cells 
(Kisselbach, Merges, Bossie, & Boyd, 2009). 
The CD105 endoglin protein is a component of 
the transforming growth factor-beta receptor 
(TGF-β) to be able to form the TGFβ receptor 
complex, but the role of CD105 in interactions 
with its league is still needed in-depth studies 
(Pierelli et al., 2001). The expression of stem 
cell surface marking proteins namely CD73, 
CD90, and CD105 will increase in the 
percentage of entry along with the increasing 
number of subcultures (passage), but there will 
be a decrease in negative surface marker 
proteins, namely CD34/CD45/CD11b/CD19/ 
HLA-DR (Varma et al., 2007; Mitchell et al., 
2006). Mitchell et al. (2006) reported that SVF 
cell surface marker proteins for CD73, CD90, 
CD105, and CD34 were 25% respectively; 
54.8%; 4.9% and 60% then when cultured until 
the first passage, the expression became 
85.3%; 90.4%; 52.8% and 21.5%. In the 4th 
passage, there was an increase in protein 
CD73, CD90, CD105, namely 94.2%; 97.2%; 
70.5% while the CD34 protein decreases to 
less than 2% which is 1.7%.  
Another study reported by Xie et al. 
(2013) showed that CD105 protein was 
expressed at a low percentage, i.e. ~60% in 
stem cells from bone marrow. Results with low 
CD105 expression values were also reported 
by De Schauwer et al. (2012), which ranges 
from 0.1% to 20%. Study of CD73, CD90, and 
CD105 protein expression with expression 
values of more than 90% reported by Barberini 
et al. (2014) in stem cells from the 3rd fat, bone 
marrow and umbilical cord tissue from the 
third passage. The results of some of these 
studies have similarities with the results of this 
study which indicate the possibility of low 
expression of CD105 due to the level of culture 
that is still small, namely the first passage. 
CONCLUSIONS AND SUGGESTIONS 
Stem cells from human fat tissue from 3 
donors have a mean length of splitting time of 
3.3 days and expressing CD73, CD90, CD105 
are 99.79% respectively; 94.17%; 48.75% and 
less than 2% detected for the CD34/CD45/ 
CD11b/CD19/HLA-DR marker. Suggestions 
for further studies are that analysis needs to be 
carried out at a higher passage using stem cells 
from human fat tissue until stable CD105 
expression is expressed. 
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